跳至内容
White paper

Improving market presence manufacturing processes and product quality with manufacturing operations management

The shift is coming. The FDA recognizes that “compliance only” has not had the intended consequences. Recalls are on the rise, and quality risk is accelerating as product complexity and change accelerate.


填写表单可立即获取

抱歉!

页面提交出错。请重新尝试。

字段为必填 必须填写有效的电子邮件地址
字段为必填 值无效或太长
字段为必填 值无效或太长
字段为必填 值无效或太长
字段为必填 值无效或太长
字段为必填 请添加有效电话号码
字段为必填 值无效或太长
字段为必填 值无效或太长
字段为必填 值无效或太长

字段为必填
字段为必填 值无效或太长
字段为必填 值无效或太长
字段为必填 值无效或太长

Some leading medical device manufacturers are ahead of the curve. They have already anticipated that shift, and implemented an infrastructure that focuses on proactive quality, with compliance being a natural byproduct of those efforts. They have invested in their product design and manufacturing processes, implementing systems that are connected and intelligent. We call such systems “closed loop,” meaning that the desired output of a process depends on the inputs, and feedback loops inform other parts of the process about the characteristics and results of that step. These systems start with R&D/ideation, support manufacturing operations and include post-market surveillance/obsolescence.